Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 271751-271800 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT00744640
Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma
PHASE1/PHASE2
Completed
46 participants
Started: Oct 31, 2005 · Completed: Dec 31, 2009
2 conditions
5 sponsors
8 locations
NCT00534664
Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma
PHASE1/PHASE2
Completed
40 participants
Started: Oct 31, 2005 · Completed: Feb 28, 2007
1 condition
1 sponsor
1 location
NCT00254878
Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14
PHASE3
Completed
130 participants
Started: Oct 31, 2005 · Completed: Feb 28, 2006
1 condition
1 sponsor
1 location
NCT00264628
GW679769 In Fibromyalgia
N/A
Completed
8 participants
Started: Oct 31, 2005 · Completed: Sep 30, 2006
3 conditions
1 sponsor
0 locations
NCT00245349
Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer
N/A
Completed
9 participants
Started: Oct 31, 2005 · Completed: Apr 30, 2008
1 condition
1 sponsor
1 location
NCT00311103
Disability of Musculoskeletal Origin in Community-dwelling Elderly
NA
Completed
214 participants
Started: Oct 31, 2005 · Completed: May 31, 2008
1 condition
5 sponsors
1 location
NCT00757029
Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD)
PHASE4
Completed
150 participants
Started: Oct 31, 2005 · Completed: Aug 31, 2010
3 conditions
1 sponsor
1 location
NCT00251550
Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
PHASE1/PHASE2
Completed
12 participants
Started: Oct 31, 2005 · Completed: Aug 31, 2006
1 condition
1 sponsor
7 locations
NCT00237250
Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance
PHASE3
Completed
171 participants
Started: Oct 31, 2005 · Completed: Jul 31, 2006
1 condition
1 sponsor
1 location
NCT00248014
Response of Individuals With Class II Malocclusion
PHASE2
Completed
63 participants
Started: Oct 31, 2005 · Completed: Apr 30, 2009
1 condition
1 sponsor
1 location
NCT00240656
Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension
PHASE1
Completed
Started: Oct 31, 2005 · Completed: May 31, 2006
1 condition
1 sponsor
1 location
NCT00253370
Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer
PHASE2
Completed
44 participants
Started: Oct 31, 2005 · Completed: Sep 30, 2010
3 conditions
1 sponsor
1 location
NCT00787930
Bipolar Disorder in Late Life
N/A
Completed
19 participants
Started: Oct 31, 2005 · Completed: Dec 31, 2011
1 condition
1 sponsor
1 location
NCT00166504
Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)
PHASE4
Completed
203 participants
Started: Oct 31, 2005 · Completed: Oct 31, 2007
1 condition
1 sponsor
0 locations
NCT00496093
Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)
PHASE3
Completed
133 participants
Started: Oct 31, 2005 · Completed: Jan 31, 2006
1 condition
1 sponsor
0 locations
NCT00575510
Intervention to Improve Follow-up of Abnormal Pap Test
NA
Completed
341 participants
Started: Oct 31, 2005 · Completed: Apr 30, 2012
1 condition
2 sponsors
1 location
NCT00182780
American Ginseng in Treating Patients With Cancer-Related Fatigue
NA
Completed
290 participants
Started: Oct 31, 2005 · Completed: Apr 30, 2010
2 conditions
2 sponsors
0 locations
NCT00823485
Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm Rupture
PHASE2/PHASE3
Completed
19 participants
Started: Oct 31, 2005 · Completed: Dec 31, 2009
2 conditions
1 sponsor
1 location
NCT00227669
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
PHASE2
Completed
90 participants
Started: Oct 31, 2005 · Completed: Aug 31, 2012
1 condition
1 sponsor
32 locations
NCT00362622
Determinants of Compliance With Glaucoma Therapy
N/A
Completed
59 participants
Started: Oct 31, 2005 · Completed: Jan 31, 2008
1 condition
2 sponsors
1 location
NCT00240253
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes
PHASE4
Completed
200 participants
Started: Oct 31, 2005 · Completed: Jun 30, 2006
1 condition
1 sponsor
34 locations
NCT00451126
Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol Response to a TSST
N/A
Completed
58 participants
Started: Oct 31, 2005 · Completed: Jan 31, 2006
1 condition
2 sponsors
1 location
NCT00528359
β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS
N/A
Completed
36 participants
Started: Oct 31, 2005 · Completed: Feb 28, 2007
1 condition
1 sponsor
1 location
NCT00786253
Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction
PHASE2
Completed
236 participants
Started: Oct 31, 2005 · Completed: Jan 31, 2007
1 condition
1 sponsor
19 locations
NCT00240968
H5 Booster After a Two Dose Schedule
PHASE2
Completed
337 participants
Started: Oct 31, 2005 · Completed: Jul 31, 2006
1 condition
1 sponsor
3 locations
NCT00596102
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
N/A
Completed
3,258 participants
Started: Oct 31, 2005
1 condition
1 sponsor
0 locations
NCT02182154
Metabolism and Pharmacokinetics of [14C]-BIBF 1120 in Healthy Male Volunteers
PHASE1
Completed
8 participants
Started: Oct 31, 2005
1 condition
1 sponsor
0 locations
NCT00204594
Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28
PHASE1/PHASE2
Completed
1 participants
Started: Oct 31, 2005 · Completed: Dec 31, 2007
1 condition
1 sponsor
1 location
NCT00612651
PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas
PHASE1
Completed
37 participants
Started: Oct 31, 2005 · Completed: Jun 30, 2011
3 conditions
2 sponsors
1 location
NCT00235573
Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption
NA
Completed
21 participants
Started: Oct 31, 2005 · Completed: Nov 30, 2005
1 condition
2 sponsors
1 location
NCT00282685
Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy
PHASE1
Completed
7 participants
Started: Oct 31, 2005 · Completed: Oct 31, 2009
1 condition
1 sponsor
1 location
NCT00657839
Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia
PHASE2
Completed
222 participants
Started: Oct 31, 2005 · Completed: Jun 30, 2006
1 condition
1 sponsor
15 locations
NCT00230230
Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED)
PHASE2
Completed
91 participants
Started: Oct 31, 2005 · Completed: Apr 30, 2007
1 condition
1 sponsor
0 locations
NCT00230789
Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.
PHASE4
Completed
417 participants
Started: Oct 31, 2005 · Completed: Dec 31, 2006
1 condition
1 sponsor
51 locations
NCT00135694
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
PHASE2
Completed
275 participants
Started: Oct 31, 2005 · Completed: Sep 30, 2015
3 conditions
2 sponsors
8 locations
NCT00213967
The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection
NA
Completed
80 participants
Started: Oct 31, 2005 · Completed: Jan 31, 2007
1 condition
1 sponsor
0 locations
NCT01197729
OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry
N/A
Completed
3,248 participants
Started: Oct 31, 2005 · Completed: Feb 28, 2010
3 conditions
4 sponsors
2 locations
NCT00244816
Taxoprexin® Treatment for Advanced Eye Melanoma
PHASE2
Completed
22 participants
Started: Oct 31, 2005 · Completed: Jun 30, 2008
1 condition
1 sponsor
1 location
NCT00767221
Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study
PHASE2
Completed
20 participants
Started: Oct 31, 2005 · Completed: Nov 30, 2008
1 condition
2 sponsors
3 locations
NCT00235391
Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
PHASE3
Completed
1,683 participants
Started: Oct 31, 2005 · Completed: Oct 31, 2008
4 conditions
1 sponsor
141 locations
NCT00139945
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
NA
Completed
8 participants
Started: Oct 31, 2005 · Completed: Mar 31, 2007
1 condition
1 sponsor
1 location
NCT00241202
The Efficacy of the HIV/AIDS Symptom Management Manual
NA
Completed
775 participants
Started: Oct 31, 2005 · Completed: Dec 31, 2006
2 conditions
8 sponsors
11 locations
NCT00246025
A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.
PHASE2
Completed
512 participants
Started: Oct 31, 2005
2 conditions
1 sponsor
38 locations
NCT00728494
Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)
N/A
Completed
99 participants
Started: Oct 31, 2005 · Completed: Dec 31, 2007
2 conditions
1 sponsor
0 locations
NCT01048294
Blue Enriched Versus Standard Light Treatment for Seasonal Affective Disorder(SAD)
NA
Completed
52 participants
Started: Oct 31, 2005 · Completed: Mar 31, 2006
1 condition
1 sponsor
1 location
NCT00618501
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
PHASE2
Completed
50 participants
Started: Oct 31, 2005 · Completed: Jan 31, 2009
1 condition
1 sponsor
1 location
NCT00250822
Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
PHASE2
Completed
11 participants
Started: Oct 31, 2005 · Completed: Jul 31, 2006
1 condition
1 sponsor
4 locations
NCT02239146
Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass
PHASE1
Completed
43 participants
Started: Oct 31, 2005 · Completed: Jan 31, 2008
2 conditions
1 sponsor
24 locations
NCT02732639
A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
PHASE3
Completed
31 participants
Started: Oct 31, 2005 · Completed: Dec 31, 2008
1 condition
1 sponsor
7 locations
NCT00460590
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
PHASE1
Completed
36 participants
Started: Oct 31, 2005 · Completed: Jun 30, 2008
1 condition
2 sponsors
1 location
Previous
1
More pages
5433
5434
5435
5436
5437
5438
5439
More pages
6093
Next